TrianglePUBLICATIONS · 38127780
FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2024 Feb 10
- First author
- Fallah J
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Fallah J
- type
- Author
- name
- Xu J
- type
- Author
- name
- Weinstock C
- type
- Author
- name
- Brave MH
- type
- Author
- name
- Bloomquist E
- type
- Author
- name
- Fiero MH
- type
- Author
- name
- Schaefer T
- type
- Author
- name
- Pathak A
- type
- Author
- name
- Abukhdeir A
- type
- Author
- name
- Bhatnagar V
- type
- Author
- name
- Chiu HJ
- type
- Author
- name
- Ricks T
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Fallah J
- type
- Author
- name
- Xu J
- type
- Author
- name
- Weinstock C
- type
- Author
- name
- Brave MH
- type
- Author
- name
- Bloomquist E
- type
- Author
- name
- Fiero MH
- type
- Author
- name
- Schaefer T
- type
- Author
- name
- Pathak A
- type
- Author
- name
- Abukhdeir A
- type
- Author
- name
- Bhatnagar V
- type
- Author
- name
- Chiu HJ
- type
- Author
- name
- Ricks T
- type
- Author
- bibliography ids
- nci-bib-7dd4464f8704ec8cfa837d5c
- book metadata
- content sha256
- e1adc9294fa7b62956c47f065594c3038029541b59d53c145b4e9a33268a5206
- document type
- citation
- dois
- 10.1200/JCO.23.01868
- electronic publication date
- display
- 2023 Dec 21
- precision
- day
- year
- 2023
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:38127780
- immutable id
- pubmed:38127780@e1adc9294fa7b62956c47f065594c3038029541b59d53c145b4e9a33268a5206
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 5
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 605-613
- volume
- 42
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 38127780
- provenance
- batch id
- 6d213eecf21b6b7867cb
- provider
- NCBI PubMed ESummary
- record sha256
- b3411c1ff9103ae430690e13b1bb8a303096e731d3e8de83cb84686bc96e2f2b
- response sha256
- 684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
- retrieved at
- 2026-09-09T23:48:19.049083+00:00
- publication date
- display
- 2024 Feb 10
- precision
- day
- year
- 2024
- publication types
- Randomized Controlled Trial
- Journal Article
- Research Support, U.S. Gov't, Non-P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer.
Preserved source evidence · Not medical advice